Combination of AD5-10 and epirubicin in treating rheumatoid arthritis / 中国医学科学院学报
Zhongguo yi xue ke xue yuan xue bao
; Zhongguo yi xue ke xue yuan xue bao;(6): 367-370, 2011.
Article
in Zh
| WPRIM
| ID: wpr-341401
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the mechanism of anti-death receptor 5-10 (AD5-10) combined with epirubicin in treating rheumatoid arthritis (RA).</p><p><b>METHODS</b>We detected the cell viability of the fibroblast-like synoviocytes (FLS) from RA patients with MTT. The expression level of apoptosis signaling pathways protein, p53, and p21 were evaluated with Western blot.</p><p><b>RESULTS</b>We found that epirubicin, at different doses, could enhance the effect of AD5-10 on FLS, promoting the apoptosis of FLS. The expression levels of caspase-3, -8, -9, c-FLIP, Bcl-2, p53, and p21 in the FLS changed after epirubicin treatment.</p><p><b>CONCLUSION</b>Epirubicin may coordinate with AD5-10 in inducing FLS apoptosis through affecting the levels of p53, p21, c-FLIP, and Bcl-2.</p>
Full text:
1
Database:
WPRIM
Main subject:
Pathology
/
Pharmacology
/
Arthritis, Rheumatoid
/
Synovial Membrane
/
Epirubicin
/
Cells, Cultured
/
Apoptosis
/
Cell Biology
/
Drug Therapy
/
Allergy and Immunology
Limits:
Humans
Language:
Zh
Journal:
Zhongguo yi xue ke xue yuan xue bao
Year:
2011
Document type:
Article